Support
Removal of Reg S restrictions from common stock | 06-Mar-2023 | 10:39 | RNS |
Director/PDMR Shareholding | 11-Oct-2022 | 18:12 | RNS |
Contract Amendment to a Central Bank | 03-Oct-2022 | 07:00 | RNS |
Exercise of Options | 21-Sep-2022 | 07:00 | RNS |
Appointment of Non-Executive Director | 12-Sep-2022 | 07:05 | RNS |
Interim Results for Six Months Ended 30 June 2022 | 12-Sep-2022 | 07:00 | RNS |
First Banknote Disinfection System Sold | 16-Aug-2022 | 07:00 | RNS |
New Central Bank Contract Amendment | 15-Aug-2022 | 07:00 | RNS |
Share Buy-Back | 28-Jul-2022 | 07:00 | RNS |
Share Buy-Back | 01-Jul-2022 | 14:31 | RNS |
Share Buy-Back | 28-Jun-2022 | 07:00 | RNS |
Additional Central Bank Development Revenues | 15-Jun-2022 | 07:00 | RNS |
Appointment of Chief Financial Officer | 14-Jun-2022 | 07:00 | RNS |
Annual General Meeting Update | 13-Jun-2022 | 07:00 | RNS |
Exercise of Options and Director/PDMR Shareholding | 25-May-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 250.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 275.00p |
52 Week Low | 170.00p |
Volume | 0 |
Shares Issued | 0.75m |
Market Cap | £1.88m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CEO | Nabil Lawandy |
You are here: research